API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.accesswire.com/845836/irlab-receives-minutes-from-end-of-phase-2-meeting-confirming-alignment-with-the-fda-on-the-phase-iii-program-for-mesdopetam
https://www.accesswire.com/731758/IRLAB-reports-Last-Patient-Last-Visit-LPLV-Achieved-in-Phase-IIb-Clinical-Study-of-Mesdopetam-in-PD-LIDs-with-Top-Line-Results-Anticipated-Mid-January-2023
https://www.accesswire.com/715500/IRLAB-Completes-Recruitment-in-Phase-IIb-Study-of-Mesdopetam-IRL790-in-Patients-with-Parkinsons-Levodopa-Induced-Dyskinesias
https://www.accesswire.com/714741/IRLABs-partner-Ipsen-Initiates-Clinical-Studies-in-Line-with-Mesdopetams-Development-Plan